Avid Bioservices, Inc. (CDMO) Q1 2025 Earnings Call Transcript Summary
Immunovant Stock Falls 8% Amid Graves' Disease Program Update
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Wall Street Today | Monday Market Climbs, But Not Past Last Weeks Fall
Avid Bioservices GAAP EPS of -$0.09 Misses by $0.03, Revenue of $40.17M Misses by $0.65M
Vir Biotechnology Announces Closing Of Exclusive Worldwide License Agreement With Sanofi For Multiple Potential Best-In-Class Clinical-Stage T-Cell Engagers; Strategic Agreement Expands Vir Portfolio With Three Clinical Stage Assets In Areas Of High...